key: cord-0885242-leg75w8u
authors: Gurgel, Ricardo Queiroz; de Sá, Laís Catarine; Souza, Daniela Raguer Valadão; Martins, Aline Fagundes; Matos, Igor Leonardo Santos; Lima, Alexandra Giovanna Aragão; Vieira, Sarah Cristina Fontes; Neto, José Melquiades de Rezende; Cuevas, Luis Eduardo; Borges, Lysandro Pinto
title: SARS-CoV-2 has been circulating in northeastern Brazil since February 2019: evidence for antibody detection in asymptomatic patients
date: 2020-12-01
journal: J Infect
DOI: 10.1016/j.jinf.2020.11.037
sha: 004cb7ba15d355150f4b1d01419c87efe1ff00ee
doc_id: 885242
cord_uid: leg75w8u

We screened stored samples collected before COVID-19 had been reported in Brazil. 989 samples were tested for SAR-CoV-2 antibodies using two different methods; 16 (1.6%) were positive (7 (43.8%) IgM, 3 (18.8%) IgG and 6 (37.5%) IgG/IgM positive), suggesting SARS-CoV-2 had circulated before the first reported COVID-19 case in Brazil.

We screened stored samples collected before COVID-19 had been reported in Brazil. 989 samples were tested for SAR-CoV-2 antibodies using two different methods; 16 (1.6%) were positive (7 (43.8%) IgM, 3 (18.8%) IgG and 6 (37.5%) IgG/IgM positive), suggesting SARS-CoV-2 had circulated before the first reported COVID-19 case in Brazil.

Grall et al (1) reports that asymptomatic patients with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) contaminate their masks and surroundings objects (mobiles, doorbell and bed table) with potential to play a role in transmission. Very few surveys focus on the prevalence of asymptomatic infections and although seroprevalence surveys provide insights of the proportion of the population infected (2, 3) and the intensity of infection, they are unable to distinguished whether a significant proportion of infections are asymptomatic.

Our country, Brazil, has the third highest global burden of Coronavirus Disease-19 (COVID-19), after the USA and India, (4) but does not systematically monitor the proportion of the population with SAR-CoV-2 antibodies. Moreover, the Ministry of Health recommends confirming the presence of the virus only in symptomatic individuals and the total number of infections is likely to be substantially higher. (5) The first case of COVID-19 in Brazil was reported the 26th February 2020 (4). However, the virus was identified in sewage samples in Santa Catarina State, in the South of Brazil, as early as the 27th November, suggesting the virus had been circulating several months earlier, and, possibly, among asymptomatic infections. (7) This situation is similar to Italy, where the virus was discovered in sewage samples in Milan, in December 2019, even though the first COVID-19 case was reported two months later, the 21st February 2020. (8) We report here evidence that SARS-CoV-2 may have circulated in the Northeast of Brazil before the first COVID-19 cases were reported in the region. In Aracaju, Sergipe State, in Northeast Brazil, the first case of COVID-19 was documented the 14th March, 2020 (4), but we report here that patients undergoing routine blood examinations for causes unrelated to COVID-19 had SARS-CoV-2 Immunoglobulins (IgM and IgG) before clinical cases were reported in the State.

We obtained 987 anonymized serum samples collected from January 2019 to April 2020. (Table) . Sixteen (1.6%) samples tested positive for both assays, 968 (98.1%) were negative and three (0.3%) were indeterminate. Thirteen of the participants with positive samples were women and three men. Seven (43.8%) samples were IgM positive, three (18.8%) IgG positive and six (37.5%) were positive for both (Table) . Legends: * A-Neighborhoods with residents with salaries above $ 2,000; B-Neighborhoods with residents with salaries $ 300 to $ 1,900; C-neighborhoods with residents with salaries below $ 300.

Viral transmission in asymptomatic cases of SARS-CoV-2 infection

Spread of SARS-CoV-2 in the Icelandic population

Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in

Secretary of Health Surveillance

Implications of social distancing in Brazil in the COVID-19 pandemic

Using Prenatal Blood Samples to Evaluate COVID-19

SARS-CoV-2 in human sewage in Santa Catarina, Brazil

SARS-CoV-2 has been circulating in northern Italy since

Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies as a Serologic Marker of Infection in Patients With Coronavirus Disease

Analysis of the timeline of events, with the evolution of SARS-CoV-2 in the world

We thank the Santa Helena Laboratory who donated the blood samples. We also thank the